Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma

Original Article

Y. Doki, J.A. Ajani, K. Kato, J. Xu, L. Wyrwicz, S. Motoyama, T. Ogata, H. Kawakami, C.-H. Hsu, A. Adenis, F.E. Hajbi, M.D. Bartolomeo, M.I. Braghiroli, E. Holtved, S.A. Ostoich, H.R. Kim, M. Ueno, W. Mansoor, W.-C. Yang, T. Liu, J. Bridgewater, T. Makino, I. Xynos, X. Liu, M. Lei, K. Kondo, A. Patel, J. Gricar, I. Chau, and Y. Kitagawa

N Engl J Med 2022;386:449-462

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation
Course opens: 
02/02/2022
Course expires: 
02/03/2024

Available Credit

  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation

Course closed

This course closed on Saturday, February 3, 2024 - 11:59pm.